Home › Funds › PFM Health Sciences, LP › EXEL
PFM Health Sciences, LP position in EXEL
EXELIXIS INC · Health Care
PFM Health Sciences, LP reported holding 188,789 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$11.0M, representing 1.13% of its reported portfolio and ranking #32 among its reported holdings. PFM Health Sciences, LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's EXEL position evolved
PFM Health Sciences, LP first disclosed a stake in EXEL in Q3 2026 at 188,789 shares (US$11.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 188.79K | $11.03M | New |
About EXEL and 13F data
EXEL (EXELIXIS INC) is a Health Care company. 40 other funds we track also report a position in EXEL — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$858.3M), Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EXEL
- FARALLON CAPITAL MANAGEMENT, L.L.C. 14.69M sh · $858.33M · Q3 2026
- Renaissance Technologies 12.79M sh · $747.22M · Q3 2026
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.80M sh · $513.77M · Q3 2026
- D. E. Shaw & Co., Inc. 5.55M sh · $302.07M · Q2 2026
- Stephens Investment Management Group LLC 2.60M sh · $151.65M · Q3 2026
- Caligan Partners LP 1.55M sh · $84.51M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held EXEL?
PFM Health Sciences, LP has disclosed EXEL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is PFM Health Sciences, LP's current position in EXEL?
As of Q3 2026, PFM Health Sciences, LP holds 188.79K shares of EXEL (EXELIXIS INC), valued at $11.03M, representing 1.13% of its reported portfolio and ranking #32.
Has PFM Health Sciences, LP been buying or selling EXEL?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP newly opened its position in EXEL.
Which other funds hold EXEL?
Other major institutional holders of EXEL include FARALLON CAPITAL MANAGEMENT, L.L.C., Renaissance Technologies, Farallon Capital Management, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.